title: Bone and bone turnover.
abstract: Children with cancer are exposed to multiple influences that may adversely affect bone health. Some treatments have direct deleterious effects on bone whilst others may have indirect effects mediated through various endocrine abnormalities. Most clinical outcome studies have concentrated on survivors of acute lymphoblastic leukaemia (ALL). There is now good evidence that earlier treatment protocols that included cranial irradiation with doses of 24 Gy or greater may result in growth hormone deficiency and low bone mineral density (BMD) in the lumbar spine and femoral neck. Under current protocols, BMD decreases during intensive chemotherapy and fracture risk increases. Although total body BMD may eventually return to normal after completion of chemotherapy, lumbar spine trabecular BMD may remain low for many years. The implications for long-term fracture risk are unknown. Risk factors for low BMD include high dose methotrexate, higher cumulative doses of glucocorticoids, male gender and low physical activity. BMD outcome in non-ALL childhood cancers has been less well studied but there is evidence that survivors of childhood brain or bone tumours, and survivors of bone marrow transplants for childhood malignancy, all have a high risk of long-term osteopenia. Long-term follow-up is required, with appropriate treatment of any endocrine abnormalities identified.
authors.forename: Patricia M
authors.initials: PM
authors.lastname: Crofton
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D016723:Bone Remodeling / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D001842:Bone and Bones / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D002648:Child; D002986:Clinical Trials as Topic; D006066:Gonads / Q000187:drug effects / Q000503:physiopathology / Q000528:radiation effects; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods; D009369:Neoplasms / Q000150:complications / Q000628:therapy; D011832:Radiation Injuries / Q000150:complications / Q000503:physiopathology; D011878:Radiotherapy / Q000009:adverse effects